OxSt, in terms of p22phox and MYPT-1 phosphorylation state, was significantly higher in untreated ADPKD patients, whereas it was significantly reduced in tolvaptan-treated ADPKD patients. Here, PPP1R12A is linked to autosomal dominant polycystic kidney disease.